Keywords: USA, Senators, Access to generics, Lipitor, Pfizer, PBMs, Insurance companies

US Senators question Pfizer deals to limit access to generic Lipitor

Article | 02 December 2011

Print This

Three prominent US Senators have sent letters to pharma behemoth Pfizer (NYSE: PF), as well as three companies that manage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in